Arch Therapeutics, Inc. (ARTH)
OTCMKTS: ARTH · Delayed Price · USD
1.180
+0.040 (3.51%)
Apr 24, 2024, 1:58 PM EDT - Market closed
Arch Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.22 | 0.75 | 2.27 | 0.96 | 2.18 | 4.67 | 5.99 | 5.04 | 3.96 | 0.83 | Upgrade
|
Cash & Cash Equivalents | 0.22 | 0.75 | 2.27 | 0.96 | 2.18 | 4.67 | 5.99 | 5.04 | 3.96 | 0.83 | Upgrade
|
Cash Growth | -70.18% | -67.05% | 136.28% | -56.00% | -53.29% | -22.13% | 19.01% | 27.18% | 375.11% | 49.56% | Upgrade
|
Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Inventory | 1.36 | 1.41 | 1.09 | 0.97 | 0.35 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Other Current Assets | 0.36 | 0.44 | 0.31 | 0.22 | 0.36 | 0.15 | 0.09 | 0.11 | 0.04 | 0.04 | Upgrade
|
Total Current Assets | 1.95 | 2.6 | 3.67 | 2.14 | 2.89 | 4.82 | 6.08 | 5.14 | 4 | 0.88 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0.01 | 0 | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 | Upgrade
|
Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0 | 0 | 0 | Upgrade
|
Total Assets | 1.96 | 2.6 | 3.68 | 2.15 | 2.9 | 4.84 | 6.09 | 5.14 | 4 | 0.88 | Upgrade
|
Accounts Payable | 2.3 | 1.33 | 0.41 | 0.34 | 0.53 | 0.16 | 0.26 | 0.37 | 0.23 | 0.18 | Upgrade
|
Deferred Revenue | 0 | 0 | -0.68 | 0 | 0 | 0 | 0 | 0 | 0.25 | 0 | Upgrade
|
Current Debt | 5.87 | 0.55 | 1 | 0.04 | 0 | 0 | 0 | 0.9 | 0.47 | 0 | Upgrade
|
Other Current Liabilities | 1.29 | 1.44 | 1 | 0.27 | 0.18 | 0.13 | 0.17 | 0.6 | 0.34 | 2.55 | Upgrade
|
Total Current Liabilities | 9.47 | 3.32 | 1.73 | 0.65 | 0.71 | 0.29 | 0.43 | 1.88 | 1.29 | 2.72 | Upgrade
|
Long-Term Debt | 0 | 2.81 | 1.6 | 0.69 | 0 | 0 | 0 | 0.08 | 0.97 | 0.96 | Upgrade
|
Other Long-Term Liabilities | 0 | 0.66 | 1.37 | 2.32 | 3 | 3.19 | 3.43 | 0.03 | 0.21 | 4.09 | Upgrade
|
Total Long-Term Liabilities | 0 | 3.48 | 2.97 | 3.01 | 3 | 3.19 | 3.43 | 0.1 | 1.18 | 5.05 | Upgrade
|
Total Liabilities | 9.47 | 6.8 | 4.7 | 3.65 | 3.71 | 3.48 | 3.86 | 1.98 | 2.46 | 7.77 | Upgrade
|
Total Debt | 5.87 | 3.36 | 1.6 | 0.73 | 0 | 0 | 0 | 0.98 | 1.44 | 0.96 | Upgrade
|
Debt Growth | 74.62% | 110.14% | 120.29% | - | - | - | - | -32.12% | 50.72% | 1.17% | Upgrade
|
Common Stock | 0 | 0.25 | 0.24 | 0.19 | 0.17 | 0.16 | 0.15 | 0.13 | 0.11 | 0.07 | Upgrade
|
Retained Earnings | -62.06 | -55.07 | -49.8 | -43.56 | -38.87 | -34.32 | -29.5 | -21.71 | -15.72 | -12.77 | Upgrade
|
Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -0.01 | -0.01 | -0 | -0 | -0 | Upgrade
|
Shareholders' Equity | -7.51 | -4.19 | -1.03 | -1.5 | -0.81 | 1.36 | 2.23 | 3.16 | 1.54 | -6.89 | Upgrade
|
Total Liabilities and Equity | 1.96 | 2.6 | 3.68 | 2.15 | 2.9 | 4.84 | 6.09 | 5.14 | 4 | 0.88 | Upgrade
|
Net Cash / Debt | -5.65 | -2.62 | 0.67 | 0.23 | 2.18 | 4.67 | 5.99 | 4.06 | 2.52 | -0.12 | Upgrade
|
Net Cash / Debt Growth | - | - | 186.10% | -89.31% | -53.29% | -22.13% | 47.69% | 61.09% | - | - | Upgrade
|
Net Cash Per Share | -1.84 | -2.18 | 0.61 | 0.25 | 2.62 | 6.11 | 8.40 | 6.68 | 6.19 | -0.36 | Upgrade
|
Working Capital | -7.52 | -0.72 | 1.94 | 1.5 | 2.18 | 4.53 | 5.65 | 3.27 | 2.72 | -1.85 | Upgrade
|
Book Value Per Share | -2.44 | -3.50 | -0.93 | -1.60 | -0.97 | 1.78 | 3.12 | 5.20 | 3.78 | -20.42 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.